iBio, Inc.IBIONYSE
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
64.52%
↑ 113% above average
Average (39q)
-509.70%
Historical baseline
Range
High:100.65%
Low:-15946.15%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 64.52% |
| Q2 2025 | 36.73% |
| Q1 2025 | -2.08% |
| Q4 2024 | -4.35% |
| Q3 2024 | 48.89% |
| Q2 2024 | -5.88% |
| Q1 2024 | 80.77% |
| Q4 2023 | 7.72% |
| Q3 2023 | 19.36% |
| Q2 2023 | 46.34% |
| Q1 2023 | 67.64% |
| Q4 2022 | -66.88% |
| Q3 2022 | 53.12% |
| Q2 2022 | -202.63% |
| Q1 2022 | -5.32% |
| Q4 2021 | 33.40% |
| Q3 2021 | -15946.15% |
| Q2 2021 | 100.65% |
| Q1 2021 | 0.00% |
| Q4 2020 | -72.56% |
| Q3 2020 | -44.33% |
| Q2 2020 | 19.30% |
| Q1 2020 | 97.12% |
| Q4 2019 | -228.57% |
| Q3 2019 | -1064.08% |
| Q2 2019 | -6.62% |
| Q1 2019 | 5.47% |
| Q4 2018 | -1.59% |
| Q3 2018 | -87.85% |
| Q2 2018 | 97.32% |
| Q1 2018 | 14.63% |
| Q4 2017 | 2.38% |
| Q3 2017 | -3359.64% |
| Q2 2017 | -10.56% |
| Q1 2017 | -21.19% |
| Q4 2016 | -5.59% |
| Q3 2016 | -12.89% |
| Q2 2016 | 18.80% |
| Q1 2016 | -28.93% |
| Q4 2015 | -24.32% |